AR100744A1 - ANTIBODIES AGAINST THE RECEIVER OF THE TUMOR NECROSIS FACTOR INDICATED BY GLUCOCORTICOIDS (GITR) AND ITS USES - Google Patents

ANTIBODIES AGAINST THE RECEIVER OF THE TUMOR NECROSIS FACTOR INDICATED BY GLUCOCORTICOIDS (GITR) AND ITS USES

Info

Publication number
AR100744A1
AR100744A1 ARP150101787A ARP150101787A AR100744A1 AR 100744 A1 AR100744 A1 AR 100744A1 AR P150101787 A ARP150101787 A AR P150101787A AR P150101787 A ARP150101787 A AR P150101787A AR 100744 A1 AR100744 A1 AR 100744A1
Authority
AR
Argentina
Prior art keywords
gitr
necrosis factor
tumor necrosis
glucocorticoids
antibodies
Prior art date
Application number
ARP150101787A
Other languages
Spanish (es)
Inventor
Li Huiming
Wong Susan
Huang Richard
Chen Guodong
Huang Haichun
Chakraborty Indrani
Minhua Han Michelle
Henning Karla
Srinivasan Mohan
J Selby Mark
J Korman Alan
Lonberg Nils
Wang Changyu
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AR100744A1 publication Critical patent/AR100744A1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Anticuerpos, o porciones de fijación al antígeno de estos, que se fijan al receptor de TNF (factor de necrosis tumoral) inducible por glucocorticoides (GITR). También, usos de estas proteínas en aplicaciones terapéuticas, tales como el tratamiento del cáncer. Además, células que producen los anticuerpos, polinucleótidos que codifican la región variable de la cadena pesada y/o liviana y vectores que comprenden los polinucleótidos que codifican la región variable de la cadena pesada y/o liviana de los anticuerpos. Molécula biespecífica, composición, kit, método.Antibodies, or antigen binding portions thereof, that bind to the glucocorticoid-inducible TNF (tumor necrosis factor) receptor (GITR). Also, uses of these proteins in therapeutic applications, such as cancer treatment. In addition, cells that produce the antibodies, polynucleotides encoding the heavy and / or light chain variable region and vectors comprising the polynucleotides that encode the heavy and / or light chain variable region of the antibodies. Bispecific molecule, composition, kit, method.

ARP150101787A 2014-06-06 2015-06-04 ANTIBODIES AGAINST THE RECEIVER OF THE TUMOR NECROSIS FACTOR INDICATED BY GLUCOCORTICOIDS (GITR) AND ITS USES AR100744A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462008945P 2014-06-06 2014-06-06

Publications (1)

Publication Number Publication Date
AR100744A1 true AR100744A1 (en) 2016-10-26

Family

ID=58699856

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150101787A AR100744A1 (en) 2014-06-06 2015-06-04 ANTIBODIES AGAINST THE RECEIVER OF THE TUMOR NECROSIS FACTOR INDICATED BY GLUCOCORTICOIDS (GITR) AND ITS USES

Country Status (2)

Country Link
AR (1) AR100744A1 (en)
MA (1) MA39559A1 (en)

Also Published As

Publication number Publication date
MA39559A1 (en) 2018-08-31

Similar Documents

Publication Publication Date Title
UY36154A (en) ANTIBODIES AGAINST THE RECEIVER OF THE TUMOR NECROSIS FACTOR INDICATED BY GLUCOCORTICOIDS (GITR) AND ITS USES
EA201891121A1 (en) ANTIBODIES TO THE GLUKORTIKOID-INDUCED RECEPTOR OF THE TUMOR NECROSIS FACTOR (GITR) AND THEIR APPLICATIONS
CL2020003028A1 (en) Anti-cd33 antibodies, anti-cd33 / anti-cd3 bispecific antibodies and their uses.
AR111288A1 (en) ANTI-PHF-TAU ANTIBODIES AND ITS USES
PH12017502129A1 (en) Antibodies against ox40 and uses thereof
CO2018000882A2 (en) Antibody constructs for flt3 and cd3
CL2018000502A1 (en) Bispecific antibodies for pd1 and tim3 useful as immunomodulators or in the treatment of cancer.
EA201790060A1 (en) BISPECIFIC CD33- and CD3-BINDING PROTEINS
PE20210488A1 (en) ANTIBODIES SPECIFIC TO GUCY2C AND ITS USES
CR20180065A (en) BIESPECTIFIC ANTIBODY CONSTRUCTS THAT JOIN EGFRVIII AND CD3
AR106365A1 (en) BISPECIFIC MOLECULES OF ANTIGEN BINDING TO T-CELL ACTIVATORS
CR20170079A (en) UNION AGENTS TO CD123 AND USES OF THESE
EA201891331A1 (en) BIPARATOPE POLYPEPTIDES - ANTAGONISTS OF TRANSMISSION OF WNT SIGNAL IN TUMOR CELLS
CU24437B1 (en) ANTI-GITR AGONIST ANTIBODIES AND COMPOSITIONS OF THE SAME
EA202191380A1 (en) ANTIBODIES TO ALPHA-SYNUCLEINE AND THEIR APPLICATION
EA201492101A1 (en) ANTIBODIES AGAINST FCRN
EA201792581A1 (en) METHODS OF APPLICATION OF BISPECIFIC CD33- and CD3-BINDING PROTEINS
CL2016000438A1 (en) Humanized antibodies that specifically bind to the colony stimulating factor 1 receptor (csf-1r); nucleic acids; expression vectors, host cells; production processes; pharmaceutical compositions; uses and methods of therapeutic treatment for the treatment of cancer and fibrotic disease
JOP20210085A1 (en) Anti-TNF?-antibodies and functional fragments thereof
EA201690992A1 (en) ANTIBODIES SPECIFIC TO FCRN
EA201891594A1 (en) ANTIBODIES TO IL-17C
AR100744A1 (en) ANTIBODIES AGAINST THE RECEIVER OF THE TUMOR NECROSIS FACTOR INDICATED BY GLUCOCORTICOIDS (GITR) AND ITS USES
EA202090533A2 (en) ANTIBODIES TO OX40 AND THEIR APPLICATION
AR107834A1 (en) ANTIBODIES THAT JOIN THE TUMOR NECROSIS FACTOR INDICATED BY GLUCOCORTICOIDS (GITR), METHODS AND USES
EA202090841A2 (en) MOLECULES BINDING WITH EGFR AND c-MET WITH TYPE III FIBRONECTIN DOMAINS